MSI2 and non-small cell lung carcinoma: Wang et al. revealed that largazole markedly suppressed cell proliferation and induced apoptosis in non-small cell lung cancer (NSCLC) and chronic myeloid leukemia (CML) by decreasing the expression of oncogenic protein Musashi-2 (MSI2) [121].